levodopa has been researched along with Catatonia in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (58.33) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 1 (8.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, H; Hatta, K; Hattori, N; Ishikawa, K; Kamigaichi, R; Kubo, S; Mochizuki, H; Ogaki, K; Usui, C; Yokoyama, K | 1 |
Aguilar-Venegas, LC; Espinola-Nadurille, M; Fricchione, GL; Merida-Puga, J; Ramirez-Bermudez, J | 1 |
Ichinose, H; Ihara, M; Ikeda, A; Kawamoto, Y; Kohara, N; Nishida, T; Saiki, H; Shibasaki, H; Takagi, S; Takao, S; Urano, F | 1 |
Kulkarni, SK; Singh, A | 1 |
West, AP | 1 |
Luther, JS; Stoudemire, A | 1 |
Jain, NK; Jain, SK; Rana, AC | 1 |
Chrétien, M; Motomatsu, T; Seidah, N | 1 |
Boucher, R; Dankova, J; Larochelle, L; Péchadre, JC; Poirier, LJ | 1 |
Neppe, VM | 1 |
Patterson, JF | 1 |
Bartholini, G; Bigler, R; Brossi, A; Burns, JJ; Kaiser, A; Pletscher, A; Pool, W; Sheppard, H | 1 |
12 other study(ies) available for levodopa and Catatonia
Article | Year |
---|---|
Effective control of catatonia in Parkinson's disease by electroconvulsive therapy: a case report.
Topics: Aged; Antiparkinson Agents; Azepines; Benzothiazoles; Cabergoline; Carbidopa; Catatonia; Catechols; Drug Therapy, Combination; Electroconvulsive Therapy; Ergolines; Female; Humans; Levodopa; Nitriles; Parkinson Disease; Pramipexole | 2009 |
Westphal variant Huntington disease and refractory catatonia: a case report.
Topics: Adult; Amantadine; Carbidopa; Catatonia; Combined Modality Therapy; Dopamine Agents; Drug Combinations; Drug Resistance; Electroconvulsive Therapy; Female; Humans; Huntington Disease; Levodopa | 2011 |
Neuroleptic malignant syndrome with prolonged catatonia in a dopa-responsive dystonia patient.
Topics: Adult; Catatonia; Dystonia; Electroencephalography; Female; GTP Cyclohydrolase; Humans; Levodopa; Neuroleptic Malignant Syndrome | 2002 |
Role of adenosine in drug-induced catatonia in mice.
Topics: Adenosine; Animals; Antiparkinson Agents; Brain; Carbidopa; Catatonia; Catechol O-Methyltransferase Inhibitors; Catechols; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Levodopa; Male; Mice; Motor Activity; Perphenazine | 2002 |
Treatments for neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Catatonia; Electroconvulsive Therapy; Fever; Humans; Levodopa; Male | 1984 |
Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Carbidopa; Catatonia; Diagnosis, Differential; Female; Haloperidol; Humans; Levodopa; Syndrome; Trihexyphenidyl | 1984 |
Brain drug delivery system bearing dopamine hydrochloride for effective management of parkinsonism.
Topics: Animals; Antiparkinson Agents; Brain; Catatonia; Dopamine; Drug Delivery Systems; Levodopa; Liposomes; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley | 1998 |
Cataleptic effect of 61-91 beta-lipotropic hormone in rat.
Topics: 5-Hydroxytryptophan; Animals; beta-Lipotropin; Catalepsy; Catatonia; Dose-Response Relationship, Drug; Humans; Levodopa; Naloxone; Rats; Sheep; Tremor | 1977 |
Stereotaxic lesions and movement disorders in monkeys.
Topics: Animals; Brain; Brain Mapping; Butyrophenones; Catalepsy; Catatonia; Cerebellum; Chorea; Haplorhini; Humans; Hypothalamus, Posterior; Levodopa; Mesencephalon; Methyltyrosines; Monoamine Oxidase Inhibitors; Motor Cortex; Movement Disorders; Parasympatholytics; Phenothiazines; Pons; Reserpine; Stereotaxic Techniques; Substantia Nigra; Tremor | 1975 |
Management of catatonic stupor with L-dopa.
Topics: Antipsychotic Agents; Catatonia; Humans; Levodopa; Psychotic Disorders | 1988 |
Akinetic parkinsonism and the catatonic syndrome: an overview.
Topics: Adult; Akinetic Mutism; Benztropine; Carbidopa; Catatonia; Humans; Levodopa; Male; Parasympatholytics; Parkinson Disease; Syndrome | 1986 |
L-DOPA: chemical modifications and biological evaluation.
Topics: Animals; Antiparkinson Agents; Blepharoptosis; Catatonia; Disease Models, Animal; Humans; Hypothermia; Levodopa; Male; Mice; Oxotremorine; Parkinson Disease; Reserpine; Structure-Activity Relationship; Tremor | 1974 |